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INTRODUCTION: The presence of xenobiotic 
metabolising enzymes in the skin is of 
considerable importance for the pharmaceutical/ 
cosmetic industries as these enzymes convert 
topically applied agents to either non-toxic or toxic 
metabolites that may lead to toxicity or 
hypersensitivity. The use of tissue engineered skin 
equivalents that replicate in vivo skin are 
extensively used in research and industry. 
However, whilst gene expression of xenobiotic 
metabolising enzymes in skin and skin equivalents 
has been detected by microarray analysis [1], data 
on protein expression and function of these 
enzymes in skin model systems is limited. Here we 
characterise gene expression and protein levels 
along with functionality of a sub-set of enzymes in 
whole skin and compare these to liver, 
commercially available and an in-house developed 
skin equivalent model to elucidate enzymatic 
profiles and activity.  
METHODS: RNA and protein extracted from 
liver, whole skin, MatTek full thickness and our in-
house skin models were used to determine gene 
expression by qPCR and protein levels using 
Western blotting. Enzyme activity and kinetics 
were assessed using commercially available 
assays. 
RESULTS: From a selection of twelve enzymes 
examined qPCR revealed that liver expressed the 
most abundant levels of enzymes whilst, in 
general, whole skin expressed slightly more 
enzyme mRNA than skin models. However, ~90% 
of selected enzymes were increased in our in-house 
model compared to the commercial MatTek model. 
Similarly, Western blotting demonstrated protein 
expression for all except two of the twelve 
enzymes in whole skin. Decreased protein 
expression was observed in skin compared to liver, 
with the exception of FMO1, NAT1, COMT and 
GSTpi which showed increased expression (Fig. 
1A). As an example, GST gene expression and 
protein levels from our in-house models is 
increased compared to MatTek models and equal 
to levels detected in skin (Fig. 1B). GST activity in 
our in house models (Fig. 1C) revealed similar 
levels of activity between the epidermal and 
dermal layers, indicating that this enzyme is 
uniformly distributed. GST specific activity peaked 
at 1 minute at a rate of 0.19 µmol/ml/min in the 
whole model.   
 
Fig. 1: Enzyme expression and activity levels. A. 
Protein expression in skin compared to liver. B. 
Gene expression, top, and protein levels, bottom, 
of GSTpi between skin and skin equivalents. C. 
GST activity in in-house skin models. GST specific 
activity in the whole model peaked at 1 min (0.19 
µmol/ml/min). 
DISCUSSION & CONCLUSIONS: Whilst at 
lower levels to liver, a high percentage of 
xenobiotic metabolising enzymes are expressed in 
the skin and skin equivalent models. We identified 
variations in enzyme expression between 
commercial and our in-house model. The main 
difference between these two models is the use of 
human dermis and not collagen as the scaffold in 
our in-house model. These data suggest that skin 
equivalents, in particular those based on dermis, 
will be a useful tool in investigating xenobiotic 
metabolism of topically delivered compounds. 
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